Associated Papers
Clinical implications of genetic variation in carboxylesterase drug metabolism.
Chen F et al.
Expert Opinion on Drug Metabolism & Toxicology, 2018
Association of carboxylesterase 1A genotypes with irinotecan pharmacokinetics in Japanese cancer patients.
Sai K et al.
British Journal of Clinical Pharmacology, 2010
Haplotypes and a novel defective allele of CES2 found in a Japanese population.
Kim SR et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2007
Pharmacogenomic assessment of carboxylesterases 1 and 2.
Marsh S et al.
Genomics, 2004
Ferredoxin reductase: pharmacogenomic assessment in colorectal cancer.
Yu J et al.
Cancer Research, 2003
Select a paper to view details